Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Net Equity Issued and Repurchased (2022 - 2025)

Updated

Raphael Pharmaceutical (RAPH) recorded Net Equity Issued and Repurchased of $3,000 in Q4 2025.

Analysis

Raphael Pharmaceutical (RAPH) Net Equity Issued and Repurchased (2022 - 2025) Analysis & Trends

For FY2025, Raphael Pharmaceutical reported Net Equity Issued and Repurchased of $243,000, down 13.2% from FY2024.

  • Across earlier years, Net Equity Issued and Repurchased came in at $280,000 in FY2024 (-75.5%) and $1.15 million in FY2023.
  • The Q4 2025 figure is the lowest quarterly Net Equity Issued and Repurchased in data going back to Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 6.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 9.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 47.70 Mn
10 Raphael Pharmaceutical 28.25 Mn 28.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3,000.00
Mar 31, 2025 240,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 180,000.00
Dec 31, 2023 19,000.00
Sep 30, 2023 812,000.00
Sep 30, 2022 112,000.00
Jun 30, 2022 302,000.00
Mar 31, 2022 10,000.00
API Access

Raphael Pharmaceutical Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RAPH&period=max&api_key=YOUR_API_KEY